TELL ME MORE ABOUT THIS STUDY

This is a dose ranging, safety and efficacy study in patients 18 – 75 with moderate to severe plaque psoriasis

Enrolling in Owensboro, KY

[contact-form-7 id=”991″ title=”Study Contact Form – Psoriasis”]